To gain a more comprehensive understanding of the extent of RBM10’s influence in SCLC, we carried out RNA-Seq, because the MTT assay used above identifies only one functional consequence resulting from inhibition of RBM10. Here, RBM10 is linked to small cell lung carcinoma.